Wells Fargo’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-31
| Closed | -$18 | – | 7781 |
|
|
2023
Q1 | $18 | Buy |
31
+1
| +3% | +$1 | ﹤0.01% | 7400 |
|
|
2022
Q4 | $21 | Buy |
30
+1
| +3% | +$2 | ﹤0.01% | 7278 |
|
|
2022
Q3 | $0 | Sell |
29
-7
| -19% | -$26 | ﹤0.01% | 7761 |
|
|
2022
Q2 | $0 | Buy |
36
+4
| +13% | +$18 | ﹤0.01% | 7857 |
|
|
2022
Q1 | $0 | Hold |
32
| – | – | ﹤0.01% | 8174 |
|
|
2021
Q4 | $0 | Hold |
32
| – | – | ﹤0.01% | 8101 |
|
|
2021
Q3 | $0 | Sell |
32
-6
| -16% | -$83 | ﹤0.01% | 7778 |
|
|
2021
Q2 | $1K | Buy |
38
+23
| +153% | +$429 | ﹤0.01% | 6798 |
|
|
2021
Q1 | $0 | Buy |
15
+10
| +200% | +$253 | ﹤0.01% | 7614 |
|
|
2020
Q4 | $0 | Buy |
5
+2
| +67% | +$30 | ﹤0.01% | 7256 |
|
|
2020
Q3 | $0 | Sell |
3
-399
| -99% | -$7.5K | ﹤0.01% | 7141 |
|
|
2020
Q2 | $6K | Hold |
402
| – | – | ﹤0.01% | 5952 |
|
|
2020
Q1 | $5K | Buy |
402
+2
| +0.5% | +$41 | ﹤0.01% | 5872 |
|
|
2019
Q4 | $12K | Buy |
400
+393
| +5,614% | +$9.4K | ﹤0.01% | 5865 |
|
|
2019
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 6850 |
|
|
2019
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 6712 |
|
|
2019
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 6580 |
|
|
2018
Q4 | $0 | Sell |
7
-18
| -72% | -$1.52K | ﹤0.01% | 6690 |
|
|
2018
Q3 | $4K | Buy |
25
+13
| +108% | +$1.92K | ﹤0.01% | 6158 |
|
|
2018
Q2 | $2K | Sell |
12
-100
| -89% | -$15.1K | ﹤0.01% | 6211 |
|
|
2018
Q1 | $28K | Buy |
112
+17
| +18% | +$4.79K | ﹤0.01% | 5737 |
|
|
2017
Q4 | $27K | Sell |
95
-10
| -10% | -$3.81K | ﹤0.01% | 5716 |
|
|
2017
Q3 | $43K | Buy |
105
+25
| +31% | +$13K | ﹤0.01% | 5522 |
|
|
2017
Q2 | $48K | Buy |
80
+8
| +11% | +$4.68K | ﹤0.01% | 5398 |
|
|
2017
Q1 | $45K | Buy |
72
+38
| +112% | +$13.5K | ﹤0.01% | 5479 |
|
|
2016
Q4 | $7K | Hold |
34
| – | – | ﹤0.01% | 5895 |
|
|
2016
Q3 | $9K | Hold |
34
| – | – | ﹤0.01% | 5789 |
|
|
2016
Q2 | $10K | Hold |
34
| – | – | ﹤0.01% | 5671 |
|
|
2016
Q1 | $14K | Sell |
34
-7
| -17% | -$2.62K | ﹤0.01% | 5602 |
|
|
2015
Q4 | $20K | Buy |
41
+4
| +11% | +$2.89K | ﹤0.01% | 5580 |
|
|
2015
Q3 | $44K | Sell |
37
-10
| -21% | -$15.3K | ﹤0.01% | 5313 |
|
|
2015
Q2 | $82K | Buy |
47
+6
| +15% | +$9.33K | ﹤0.01% | 5163 |
|
|
2015
Q1 | $48K | Buy |
41
+3
| +8% | +$3.55K | ﹤0.01% | 5032 |
|
|
2014
Q4 | $38K | Sell |
38
-22
| -37% | -$22K | ﹤0.01% | 5126 |
|
|
2014
Q3 | $81K | Hold |
60
| – | – | ﹤0.01% | 4743 |
|
|
2014
Q2 | $102K | Sell |
60
-7
| -10% | -$13.3K | ﹤0.01% | 4672 |
|
|
2014
Q1 | $151K | Buy |
67
+48
| +253% | +$123K | ﹤0.01% | 4466 |
|
|
2013
Q4 | $39K | Buy |
19
+9
| +90% | +$19.4K | ﹤0.01% | 4824 |
|
|
2013
Q3 | $30K | Buy |
+10
| New | +$17.1K | ﹤0.01% | 4839 |
|
Other funds holding VYNT
Wells Fargo's VYNT Position: Q2 2023 in Review
Wells Fargo sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2023, closing a stake of 31 shares — an estimated $18 sold.
Wells Fargo first reported a position in VYNT in Q3 2013 and held it in 39 quarters. The position peaked at $151K in Q1 2014. 1 fund tracked by Wall St. Rank holds VYNT as of Q2 2023.
- Wells Fargo reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Wells Fargo sold 31 Vyant Bio, Inc. Common Stock shares in Q2 2023, an estimated $18.
- Wells Fargo first reported a position in Vyant Bio, Inc. Common Stock in Q3 2013 and held it in 39 quarters.
- Wells Fargo's Vyant Bio, Inc. Common Stock position peaked at $151K in Q1 2014.
- 1 fund tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2023.
Based on Wells Fargo's 13F filing for Q2 2023, filed 15 Aug 2023.